$1.06B
$1.84 Million
0.0% of portfolio
280,602
Q2 2025
Reduced 14.74%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 17.78%
$2.93B
$8.68 Million
0.0% of portfolio
310,407
Q2 2025
Added 9.46%
$3.37B
$3.67 Million
0.0% of portfolio
30,270
Q2 2025
Reduced 24.18%
$1.13B
$6.27 Million
0.0% of portfolio
1,311,093
Q2 2025
Added 121.23%
$765M
$3.11 Million
0.0% of portfolio
425,083
Q2 2025
Added 22.97%
$309M
$347,000
0.0% of portfolio
13,633
Q2 2025
New
$121M
$897,000
0.0% of portfolio
550,604
Q2 2025
Added 53.87%
$640M
$3 Million
0.0% of portfolio
950,610
Q2 2025
Reduced 18.43%
$989M
$1.14 Million
0.0% of portfolio
431,100
Q2 2025
Added 19.86%
$120M
$2.25 Million
0.0% of portfolio
241,410
Q2 2025
Added 0.61%
$3.55B
$6.19 Million
0.0% of portfolio
225,099
Q2 2025
Reduced 3.8%
$51B
$15 Million
0.0% of portfolio
188,844
Q2 2025
Reduced 0.25%
$3.05B
$6.42 Million
0.0% of portfolio
102,009
Q2 2025
Reduced 52.36%
$669M
$11.7 Million
0.0% of portfolio
361,709
Q2 2025
Reduced 15.13%
$529M
$1.36 Million
0.0% of portfolio
380,796
Q2 2025
Reduced 5.35%
$376M
$573,000
0.0% of portfolio
126,042
Q2 2025
Reduced 6.1%
$5.9B
$3.83 Million
0.0% of portfolio
157,171
Q2 2025
Added 16.0%
$240M
$240,000
0.0% of portfolio
50,044
Q2 2025
Reduced 26.69%
$92.1B
$2.79 Million
0.0% of portfolio
127,703
Q2 2025
Reduced 31.19%
$2.05B
$3.63 Million
0.0% of portfolio
84,169
Q2 2025
Reduced 21.19%
-
$0
0.0% of portfolio
-
Q1 2025
New
$924M
$1.91 Million
0.0% of portfolio
30,091
Q2 2025
Reduced 16.78%
-
$0
0.0% of portfolio
-
Q2 2025
Added 35.23%
Inhibikase Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 15.22%
$1.17B
$14.7 Million
0.0% of portfolio
286,969
Q2 2025
Reduced 16.31%
$5.59B
$6.14 Million
0.0% of portfolio
84,565
Q2 2025
Reduced 22.97%
$994M
$1.82 Million
0.0% of portfolio
84,391
Q2 2025
Reduced 29.87%
$829M
$4.55 Million
0.0% of portfolio
192,860
Q2 2025
Reduced 13.1%
$526M
$1.27 Million
0.0% of portfolio
123,258
Q2 2025
Reduced 20.25%
$441M
$897,000
0.0% of portfolio
45,287
Q2 2025
Reduced 20.41%
$959M
$1.9 Million
0.0% of portfolio
30,339
Q2 2025
Reduced 19.18%
Tonix Pharmaceuticals Hldg C
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.59B
$897,000
0.0% of portfolio
26,834
Q2 2025
New
$222M
$155,000
0.0% of portfolio
52,716
Q2 2025
Added 30.92%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 7.67%
$2.57B
$14.3 Million
0.0% of portfolio
418,094
Q2 2025
Reduced 8.28%
$265B
$3.65 Million
0.0% of portfolio
21,161
Q2 2025
Reduced 10.56%
$163M
$75,000
0.0% of portfolio
44,174
Q2 2025
Reduced 39.31%
$3.32B
$2.3 Million
0.0% of portfolio
212,983
Q2 2025
Reduced 3.34%
$627M
$1.48 Million
0.0% of portfolio
17,247
Q2 2025
Reduced 18.27%
$4.17B
$10.4 Million
0.0% of portfolio
77,316
Q2 2025
Reduced 12.24%
$362M
$606,000
0.0% of portfolio
103,205
Q2 2025
Reduced 59.16%
$259M
$659,000
0.0% of portfolio
74,899
Q2 2025
Reduced 68.89%
$1.02B
$2.22 Million
0.0% of portfolio
114,451
Q2 2025
Reduced 18.57%
$428M
$926,000
0.0% of portfolio
169,459
Q2 2025
Reduced 38.07%
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.43B
$2.64 Million
0.0% of portfolio
65,099
Q2 2025
Reduced 27.07%
$1.5B
$7.86 Million
0.0% of portfolio
274,831
Q2 2025
Added 8.55%